Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling

Gang Cao, Ruyi Zhu, Ting Jiang, Dongxin Tang, Hiu Yee KWAN, Tao Su*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds